A combination of silybin and carvedilol is more effective than either drug alone for treating liver fibrosis, found a new study published in Targetome. Liver fibrosis is a chronic and multifactorial ...
WASHINGTON (Reuters) - GlaxoSmithKline Plc said on Friday it won U.S. approval to sell a new once- a-day formulation of its Coreg hypertension drug. The new version, Coreg CR, is designed to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results